Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          

SB01

SB01

An anti-cancer NCE with multiple anti-tumor MOA.Promising results lead to potential indications:Head and Neck Cancer and Cholangiocarcinoma.Phase II trial is ongoing in Taiwan.

Request for Collaboration
Overview
SB01 is a new drug originated in Taiwan, from discovery, research and development, preclinical ADME, API and finished product manufactured to the USFDA IND. 
 
  • SB01 is an injectable anti-cancer NCE with multiple anti-tumor MOA
  • Treatement of cholangiocarcinoma has FDA Orphan Drug Designation clearance
  • Phase I results show a favorable safety profile
  • Phase II clinical trial of SB01 has been conducting in Taiwan
Application
Potential indications:
 
  • Head and Neck cancer
  • Cholangiocarcinoma
  • Other solid tumors
Collaboration Options
  • Co-develop
  • Tech transfer
  • Licensing
People who like this also like
  • Platform_Antibody-Linked NanomedicinesPlatform_Antibody-Linked Nanomedicines
  • Breast Image Matching Method and Image Processing ApparatusBreast Image Matching Method and Image Processing Apparatus
  • Lead discoveryLead discovery
  • Cancer screening by next generation sequencingCancer screening by next generation sequencing
  • PHN013 (Orphan drug;ITP)PHN013 (Orphan drug;ITP)
  • RD statusRD status
  • Decellularization matrixDecellularization matrix
  • Stabilized Injectable Formulation - SIFStabilized Injectable Formulation - SIF
  • Newborn genetic screening for hearing impairment using real-time PCR with FRET probesNewborn genetic screening for hearing impairment using real-time PCR with FRET probes
  • LT3001LT3001